Surgical and interventional therapies for pulmonary arterial hypertension

Seminars in Respiratory and Critical Care Medicine

Volumn 26, Issue 4, 2005, Pages 417-428

  Olsson, Julie K ^a   Zamanian, Roham T ^a   Feinstein, Jeffrey A ^a   Doyle, Ramona L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial septostomy; Congenital heart disease; Lung and heart lung transplantation; Pulmonary arterial hypertension; Pulmonary thromboendarterectomy

Indexed keywords

BLALOCK HANLON OPERATION; DISEASE ASSOCIATION; DISEASE COURSE; ENDARTERECTOMY; HEART FAILURE; HEART LUNG TRANSPLANTATION; HEART SURGERY; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LUNG ARTERIOVENOUS SHUNT; LUNG TRANSPLANTATION; PALLIATIVE THERAPY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; THROMBOEMBOLISM; TREATMENT INDICATION; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON; ENDARTERECTOMY; HEART SEPTUM; HEART-LUNG TRANSPLANTATION; HUMANS; HYPERTENSION, PULMONARY; LUNG TRANSPLANTATION; PALLIATIVE CARE; PATIENT SELECTION; PULMONARY EMBOLISM; REOPERATION;

EID: 24644464697     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-916157     Document Type: Review

References (88)

1. Kerstein D, Levy PS, Hsu DT, Hordof AJ, Gersony WM, Barst RJ. Blade balloon atrial septogstomy in patients with severe primary pulmonary hypertension. Circulation 1995; 91:2028-2035
2. Allcock RJ, O'Sullivan JJ, Corris PA. Atrial septostomy for pulmonary arterial hypertension. Heart 2003;89:1344-1347
3. Rich S, Dodin E, McLaughlin VV. Usefulness of atrial septostomy as a treatment for primary pulmonary hypertension and guidelines for its application. Am J Cardiol 1997; 80:369-371
4. Reichenberger F, Pepke-Zaba J, McNeil K, Parameshwar J, Shapiro LM. Atrial septostomy in the treatment of severe pulmonary arterial hypertension. Thorax 2003;58:797-800
5. Rothman A, Sklansky MS, Lucas VW, et al. Atrial septostomy as a bridge to lung transplantation in patients with severe pulmonary hypertension. Am J Cardiol 1999;84:682-686
6. Khan MA, Bricker JT, Mullins CE, Yousef SA, Nihill MR, Vargo TA. Blade atrial septostomy: experience with the first 50 procedures. Cathet Cardiovasc Diagn 1991;23:257-262
7. Sandoval J, Gaspar J, Pulido T, et al. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension: a therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol 1998;32:297-304
8. Barst RJ. Role of atrial septostomy in the treatment of pulmonary vascular disease. Thorax 2000;55:95-96
9. Pengo V, Lensing AW, Prins MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004;350:2257-2264
10. Daily PO, Dembitsky WP, Jamieson SW. The evolution and the current state of the art of pulmonary thromboendarterectomy. Semin Thorac Cardiovasc Surg 1999;11:152-163
11. Fishman AJ, Moser KM, Fedullo PF. Perfusion lung scans vs pulmonary angiography in evaluation of suspected primary pulmonary hypertension. Chest 1983;84:679-683
12. Ryan KL, Fedullo PF, Davis GB, Vasquez TE, Moser KM. Perfusion scan findings understate the severity of angiographic and hemodynamic compromise in chronic thromboembolic pulmonary hypertension. Chest 1988;93:1180-1185
13. Auger WR, Fedullo PF, Moser KM, Buchbinder M, Peterson KL. Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology 1992;182: 393-398
14. Straube KR, Dotter CT, O'Dell J. Death following selective right ventricular angiocardiography: a case report. Radiology 1963;80:616-621
15. Watson H. Severe pulmonary hypertensive episodes following angiocardiography with sodium metrizoate. Lancet 1964;171: 732-733
16. Mills SR, Jackson DC, Older RA, Heaston DK, Moore AV. The incidence, etiologies, and avoidance of complications of pulmonary angiography in a large series. Radiology 1980;136: 295-299
17. Nicod P, Peterson K, Levine M, et al. Pulmonary angiography in severe chronic pulmonary hypertension. Ann Intern Med 1987;107:565-568
18. Hofmanu LV, Lee DS, Gupta A, et al. Safety and hemodynamic effects of pulmonary angiography in patients with pulmonary hypertension: 10-year single-center experience. AJR Am J Roentgenol 2004;183:779-786
19. Pitton MB, Duber C, Mayer E, Thelen M. Hemodynamic effects of nonionic contrast bolus injection and oxygen inhalation during pulmonary angiography in patients with chronic major-vessel thromboembolic pulmonary hypertension. Circulation 1996;94:2485-2491
20. Tardivon AA, Musset D, Maitre S, et al. Role of CT in chronic pulmonary embolism: comparison with pulmonary angiography. J Comput Assist Tomogr 1993;17:345-351
21. Bergin CJ, Sirlin CB, Hauschildt JP, et al. Chronic thromboembolism: diagnosis with helical CT and MR imaging with angiographic and surgical correlation. Radiology 1997;204:695-702
22. Ley S, Kauczor HU, Heussel CP, et al. Value of contrast-enhanced MR angiography and helical CT angiography in chronic thromboembolic pulmonary hypertension. Eur Radiol 2003;13:2365-2371
23. Kreitner KF, Ley S, Kauczor HU, et al. Chronic thromboembolic pulmonary hypertension: pre- and postoperative assessment with breath-hold MR imaging techniques. Radiology 2004;232:535-543
24. Moser KM, Auger WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation 1990; 81:1735-1743
25. Tscholl D, Langer F, Wendler O, Wilkens H, Georg T, Schafers HJ. Pulmonary thromboendarterectomy: risk factors for early survival and hemodynamic improvement. Eur J Cardiothorac Surg 2001;19:771-776
26. Gilbert TB, Gaine SP, Rubin LJ, Sequeira AJ. Short-term outcome and predictors of adverse events following pulmonary thromboendarterectomy. World J Surg 1998;22:1029-1032 discussion 33
27. Barzaghi N, Maurelli M, Emmi V, et al. Pulmonary thromboendarterectomy in a patient with cryoagglutinins. J Cardiothorac Vasc Anesth 2000;14:447-448
28. Yung GL, Channick RN, Fedullo PF, et al. Successful pulmonary thromboendarterectomy in two patients with sickle cell disease. Am J Respir Crit Care Med 1998;157(5 Pt 1):1690-1693
29. Jamieson SW, Auger WR, Fedullo PF, et al. Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. J Thorac Cardiovasc Surg 1993;106:116-126 discussion 26-27
30. Moser KM, Spragg RG, Utley J, Daily PO. Chronic thrombotic obstruction of major pulmonary arteries: results of thromboendarterectomy in 15 patients. Ann Intern Med 1983;99:299-304
31. Ando M, Okita Y, Tagusari O, Kitamura S, Nakanishi N, Kyotani S. Surgical treatment for chronic thromboembolic pulmonary hypertension under profound hypothermia and circulatory arrest in 24 patients. J Card Surg 1999;14:377-385
32. Menzel T, Wagner S, Kramm T, et al. Pathophysiology of impaired right and left ventricular function in chronic embolic pulmonary hypertension: changes after pulmonary thromboendarterectomy. Chest 2000;118:897-903
33. Kapitan KS, Clausen JL, Moser KM. Gas exchange in chronic thromboembolism after pulmonary thromboendarterectomy. Chest 1990;98:14-19
34. Moser KM, Auger WR, Fedullo PF, Jamieson SW. Chronic thromboembolic pulmonary hypertension: clinical picture and surgical treatment. Eur Respir J 1992;5:334-342
35. Chitwood WR Jr, Sabiston DC Jr, Wechsler AS. Surgical treatment of chronic unresolved pulmonary embolism. Clin Chest Med 1984;5:507-536
36. Mayer E, Kramm T, Dahm M, et al. Early results of pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension. Z Kardiol 1997;86:920-927
37. Miller WT Jr, Osiason AW, Langlotz CP, Palevsky HI. Reperfusion edema after thromboendarterectomy: radiographic patterns of disease. J Thorac Imaging 1998;13:178-183
38. Auger W, Fedullo PF, Moser K. In-hospiral mortality has decreased for patients undergoing pulmonary thromboendarterectomy [abstract]. Am J Respir Crit Care Med 1996; 153:A92
39. Kerr KM, Auger WR, Marsh JJ, et al. The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy. Am J Respir Crit Care Med 2000;162:14-20
40. Mares P, Gilbert TB, Tschernko EM, et al. Pulmonary artery thromboendarterectomy: a comparison of two different postoperative treatment strategies. Anesth Analg 2000;90:267-273
41. Archibald CJ, Auger WR, Fedullo PF, et al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med 1999;160:523-528
42. Mo M, Kapelanski DP, Mitruka SN, et al. Reoperative pulmonary thromboendarterectomy. Ann Thorac Surg 1999; 68:1770-1776 discussion 6-7
43. Feinstein JA, Goldhaber SZ, Lock JE, Ferndandes SM, Landzberg MJ. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation 2001;103:10-13
44. Reitz BA, Wallwork JL, Hunt SA, et al. Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med 1982;306:557-564
45. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. The Registry of the International Society for Heart and Lung Transplantation: twenty-first official adult heart transplant report-2004. J Heart Lung Transplant 2004;23:804-815
46. D'Alonzo GE, Barst RJ, Ayres SM, et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 1991;115:343-349
47. Shapiro SM, Oudiz RJ, Cao T, et al. Primary pulmonary hypertension: improved long-term effects and survival with continuous intravenous epoprostenol infusion. J Am Coll Cardiol 1997;30:343-349
48. McLaughlin VV, Genthner DE, Panella MM, Rich S. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med 1998;338:273-277
49. Maurer JR, Frost AE, Estenne M, Higenbottam T, Glanville AR. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. Transplantation 1998;66:951-956
50. Hopkins WE, Ochoa LL, Richardson GW, Trulock EP. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant 1996;15(1 Pt 1):100-105
51. Hopkins WE, Waggoner AD. Severe pulmonary hypertension without right ventricular failure: the unique hearts of patients with Eisenmenger syndrome. Am J Cardiol 2002;89: 34-38
52. Kidd L, Driscoll D, Gersony W, et al. Second natural history study of congenital heart defects, results of treatment of patients with ventricular septal defects. Circulation 1993; 87(suppl 2):I38-51
53. Jamieson SW, Stinson EB, Oyer PE, et al. Heart-lung transplantation for irreversible pulmonary hypertension. Ann Thorac Surg 1984;38:554-562
54. Kramer MR, Marshall SE, Tiroke A, Lewiston NJ, Starnes VA, Theodore J. Clinical significance of hyperbilirubinemia in patients with pulmonary hypertension undergoing heart-lung transplantation. J Heart Lung Transplant 1991;10:317-321
55. Levine SM. A survey of clinical practice of lung transplantation in North America. Chest 2004;125:1224-1238
56. Kasimir MT, Seebacher G, Jaksch P, et al. Reverse cardiac remodelling in patients with primary pulmonary hypertension after isolated lung transplantation. Eur J Cardiothorac Surg 2004;26:776-781
57. Bando K, Armitage JM, Paradis IL, et al. Indications for and results of single, bilateral, and heart-lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg 1994;108: 1056-1065
58. Boujoukos AJ, Martich GD, Vega JD, Keenan RJ, Griffith BP. Reperfusion injury in single-lung transplant recipients with pulmonary hypertension and emphysema. J Heart Lung Transplant 1997;16:439-448
59. Ueno T, Smith JA, Snell GI, et al. Bilateral sequential single lung transplantation for pulmonary hypertension and Eisenmenger's syndrome. Ann Thorac Surg 2000;69:381-387
60. Mendeloff EN, Meyers BF, Sundt TM, et al. Lung transplantation for pulmonary vascular disease. Ann Thorac Surg 2002;73:209-217 discussion 17-19
61. Chapelier A, Vouhe P, Macchiarini P, et al. Comparative outcome of heart-lung and lung transplantation for pulmonary hypertension. J Thorac Cardiovasc Surg 1993;106:299-307
62. Whyte RI, Robbins RC, Altinger J, et al. Heart-lung transplantation for primary pulmonary hypertension. Ann Thorac Surg 1999;67:937-941 discussion 41-42
63. Franke UF, Wahlers T, Wittwer T, et al. Heart-lung transplantation is the method of choice in the treatment of patients with end-stage pulmonary hypertension. Transplant Proc 2002;34:2181-2182
64. Sharples LD, Tamm M, McNeil K, Higenbottam TW, Stewart S, Wallwork J. Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation: early risk factors. Transplantation 1996;61:560-566
65. Goetzmann L, Scheuer E, Naef R, et al. Psychosocial situation and physical health in 50 patients > 1 year after lung transplantation. Chest 2005;127:166-170
66. Gross CR, Savik K, Bolman RM III, Hertz MI. Long-term health status and quality of life outcomes of lung transplant recipients. Chest 1995;108:1587-1593
67. TenVergert EM, Essink-Bot ML, Geertsma A, van Enckevort PJ, de Boer WJ, van der Bij W. The effect of lung transplantation on health-related quality of life: a longitudinal study. Chest 1998;113:358-364
68. Grossman W. Grossman's Cardiac Catherization, Angiography, and Intervention. 6th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2000
69. Moodie DS, Sterba R. Long-term outcomes excellent for atrial septal defect repair in adults. Cleve Clin J Med 2000; 67:591-597
70. Gersony WM, Rosenbaum MS. Congenital Heart Disease in the Adult. New York, NY: McGraw-Hill; 2002
71. Wu JC, Child JS. Common congenital heart disorders in adults. Curr Probl Cardiol 2004;29:641-700
72. Walker RE, Moran AM, Gauvreau K, Colan SD. Evidence of adverse ventricular interdependence in patients with atrial septal defects. Am J Cardiol 2004;93:1374-1377, A6
73. Cherian G, Uthaman CB, Durairaj M, et al. Pulmonary hypertension in isolated secundum atrial septal defect: high frequency in young patients. Am Heart J 1983;105:952-957
74. Berger F, Vogel M, Kramer A, et al. Incidence of atrial flutter/fibrillation in adults with atrial septal defect before and after surgery. Ann Thorac Surg 1999;68:75-78
75. Horvath KA, Burke RP, Collins JJ Jr, Cohn LH. Surgical treatment of adult atrial septal defect: early and long-term results. J Am Coll Cardiol 1992;20:1156-1159
76. Gatzoulis MA, Freeman MA, Siu SC, Webb GD, Harris L. Atrial arrhythmia after surgical closure of atrial septal defects in adults. N Engl J Med 1999;340:839-846
77. Silversides CK, Siu SC, McLaughlin PR, et al. Symptomatic atrial arrhythmias and transcatheter closure of atrial septal defects in adult patients. Heart 2004;90:1194-1198
78. Masura J, Gavora P, Formanek A, Hijazi ZM. Transcatheter closure of secundum atrial septal defects using the new self-centering amplatzer septal occluder: initial human experience. Cathet Cardiovasc Diagn 1997;42:388-393
79. Masura J, Gavora P, Podnar T. Long-term outcome of transcatheter secundum-type atrial septal defect closure using Amplatzer septal occluders. J Am Coll Cardiol 2005;45:505-507
80. Chessa M, Carminati M, Butera G, et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002;39: 1061-1065
81. Steele PM, Fuster V, Cohen M, Ritter DG, McGoon DC. Isolated atrial septal defect with pulmonary vascular obstructive disease: long-term follow-up and prediction of outcome after surgical correction. Circulation 1987;76:1037-1042
82. John Sutton MG, Tajik AJ, McGoon DC. Atrial septal defect in patients ages 60 years or older: operative results and long-term postoperative follow-up. Circulation 1981;64:402-409
83. Murphy JG, Gersh BJ, McGoon MD, et al. Long-term outcome after surgical repair of isolated atrial septal defect: follow-up at 27 to 32 years. N Engl J Med 1990;323:1645-1650
84. Andersen M, Lyngborg K, Moeller I, Wennevold A. The natural history of small atrial septal defects: long-term follow-up with serial heart catheterizations. Am Heart J 1976;92: 302-307
85. Neutze JM, Ishikawa T, Clarkson PM, Calcer AL, Barratt-Boyes BG, Kerr AR. Assessment and follow-up of patients with ventricular septal defect and elevated pulmonary vascular resistance. Am J Cardiol 1989;63:327-331
86. Kirklin JW, DuShane JW. Indications for repair of ventricular septal defects. Am J Cardiol 1963;12:75-79
87. Knauth AL, Lock JE, Perry SB, et al. Transcatheter device closure of congenital and postoperative residual ventricular septal defects. Circulation 2004;110:501-507
88. Holzer R, Balzer D, Cao QL, Lock K, Hijazi ZM. Device closure of muscular ventricular septal defects using the Amplatzer muscular ventricular septal defect occluder: immediate and mid-term results of a U.S. registry. J Am Coll Cardiol 2004;43:1257-1263